Company Overview
Snapshot
Founded in January 2012 by Arie Goldhust, Datum Dental operated with 11–50 employees. The company was acquired by Dentsply Sirona in January 2021, marking a significant exit in the dental biomaterials sector.
Business overview
Datum Dental specializes in developing sugar cross-linked collagen products for bone and soft tissue regeneration in dentistry. The company's core technology, GLYMATRIX, enables the creation of collagen-based biomatrices for medical devices with enhanced stability and long-lasting effects. Its product portfolio, including OSSIX Plus, OSSIX Volumax, and OSSIX Bone, serves the regenerative dentistry market globally, catering to both clinicians and patients.
Strategic signal
In January 2021, Datum Dental was acquired by Dentsply Sirona. This acquisition by a major dental product manufacturer validates Datum Dental's proprietary GLYMATRIX collagen cross-linking technology and its OSSIX regenerative solutions, signaling strong market demand for advanced biomaterials in dental applications and a successful strategic exit for the company.
Company Intelligence Q&A
- What was a significant corporate milestone for Datum Dental?
- Datum Dental was acquired by Dentsply Sirona in January 2021. This acquisition integrated Datum Dental's regenerative dentistry products into a larger global dental solutions provider.
- What regulatory approvals did Datum Dental achieve for its OSSIX Bone product?
- In June 2018, Datum Dental secured CE Mark and Health Canada Regulatory Approvals for its OSSIX Bone product, expanding its market access for this regenerative dental solution.
- Did Datum Dental establish any distribution agreements?
- In April 2018, Datum Dental, Ltd. and Dentsply Sirona Implants entered into a distribution agreement for the USA, enhancing the reach of Datum Dental's products in the American market.
- Who are the founders of Datum Dental?
- Datum Dental was co-founded by Arie Goldhust, who also served as VP R&D.
- What is Datum Dental's primary product line?
- Datum Dental's primary product line, known as OSSIX Regenerative Solutions, includes.